Skip to main content

Rocket Pharmaceuticals, Inc.

RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001281895

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q2 2026 vs. Q1 2026

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of RCKT: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1993180−16
Shares97.2M186.2K99.7M+2.66M (+2.7%)
Value$347.9M$666.5K$340.9M−$6.32M (−1.8%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (18)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to RCKT in Q2 2026
InstitutionSharesValue% of portfolio
Qube Research & Technologies Ltd644,869$2.21M0.00%
Los Angeles Capital Management LLC348,093$1.19M0.00%
BIT Capital GmbH298,000$1.02M0.03%
Public Employees Retirement System of Ohio135,100$462.0K0.00%
Jain Global LLC134,665$460.6K0.01%
Schonfeld Strategic Advisors LLC110,666$378.5K0.00%
Weiss Asset Management LP86,064$294.3K0.00%
Citadel Advisors LLC71,170$243.4K0.00%
Wellington Management Group LLP61,605$210.7K0.00%
Walleye Capital LLC60,411$206.6K0.00%
Commonwealth Equity Services, LLC29,520$101.0K0.00%
Dynamic Technology Lab Private Ltd23,398$80.0K0.02%
HB Wealth Management, LLC10,541$36.0K0.00%
Wealth Enhancement Trust Services, Inc.459$1.57K0.00%
Bare Financial Services, Inc340$1.16K0.00%
Zions Bancorporation, National Association202$6910.00%
Clearstead Advisors, LLC122$4190.00%
Global Retirement Partners, LLC19$650.00%

Sold out (34)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (3)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC174,263$623.9K
Skopos Labs, Inc.11,825$42.3K
Sunbelt Securities, Inc.90$322